finished products had not been made. It was therefore decided to test auramine experimentally for carcinogenic activity in the rat (at Manchester) and the mouse (at Leeds).
Auramine is a yellow dye, used widely to colour cardboard. It has the composition 4:4'-bis(dimethylamino)benzophenone-imiiie hydrochloride. 
At Manchester
The rats were males from the " Wilmslow Wistar " closed colony and were 8-10 weeks of age at the start of treatment. The standard diet was Scottish Agricultural Industries ret cubes, to which additions were made as required. 
At Leeds
The mice were either "stock" albino, bought from a dealer, or belonged to the CBA strain, which has been inbred in the laboratory since 1933. They were approximately 12 weeks of age at the start of treatment. The chemical was obtained from the British Drug Houses. The standard diet was rat cake 86, bought from the N.E. Agricultural Co-operative Society, Aberdeen, and water ad libitum.
Experiments 3 and 4.-Auramine was dissolved in acetone and mixed well with rat cake powder to give a concentration of 0.1, 0*2 or 0.3 per cent. A stiff dough was made with water and was dried in the warm oven in flat cakes, which were fed ad libitum together with drinking water.
RESULTS
Experiment 1.-In Table I it is seen that 92 per cent of the male rats which received a large dose of auramine over a period of 87 weeks developed hepatomas A few other tumours were observed. At 99 weeks a rat bearing a small hepatoma had in addition a spindle cell malignant tumour at the side of the head. This was diagnosed as a spindle cell sarcoma, but the possibility of spindle cell anaplasia in an acoustic duct carcinoma could not be excluded. At 113 weeks, one rat bearing large multiple hepatomas had a well differentiated adenocarcinoma of one kidney and also an early transitional cell carcinoma of the bladder. Twelve control rats receiving a diet of rat cake and malt were tumour free at death between 90 and 129 weeks (Table 1) .
Experiment 2.-Twenty of 24 male rats survived 21 weeks of subcutaneous injection of auramine. The total dose given was 110-120 mg. (Table II) . Eleven rats died between 40 and 89 weeks, 9 with subcutaneous fibrosarcomas and without A few other tumours occurred in stock mice but none in CBA mice In a male treated for 67 weeks there was a reticulum cell sarcoma, especially prominent in the liver and around the salivary glands, and a deeply invading adenocarcinoma of the mid-colon. In another male treated for 56 weeks there was a spindle cell sarcoma of the subcutaneous tissues of the flank. This was unlike the reticulum cell sarcoma in structure, was localised and not associated with parasitic or other visible infection. In another male treated for 79 weeks there was a benign interstitial cell tumour of the testis.
Morphology of the tumourS
In all groups the hepatomas ranged in size from microscopical to large masses occupying the whole liver lobe. In structure they ranged from well differentiated benign tumours to anaplastic malignant-looking ones. No metastases were seen.
DISCUSSION
Case and Pearson (1954) showed that workers engaged in the manufacture of auramine ran a risk of developing papilloma and carcinoma of the bladder. The present experiments demonstrate that this compound is carcinogenic to the liver of rats and mice when administered orally in large doses. When administered subcutaneously to rats in a small dose a few hepatomas occurred together with subcutaneous fibrosarcomas. The latter are not regarded as necessarily due to the chemical. Only one bladder tumour was found in an experimental animal a rat-but this species divergence in location of tumours between man and rodents is well known in aromatic amine careinogenesis.
In stock mice the hepatomas occurred in livers in which cirrhosis and bile duct proliferation was minimal. In CBA mice and rats there was mild cirrhosis and bile duct proliferation with the formation of cholangiomas. These changes were far Cd less advanced than in mice and rats treated with butter yellow (Orr, 1940) 
